Table 1.

Baseline Characteristics

	Treated (n = 20)	Control (n = 13)	P
Age	57.6 (1.9)	55.8 (2.5)	0.565
Race
Caucasian	19 (95%)	12 (92%)	0.693
African american	1 (5%)	1 (8%)
Male sex	18 (90%)	12 (92%)	0.667
Body mass index (kg/m2)	29.7 (1.0)	27.7 (1.3)	0.210
Diabetes mellitus	5 (25%)	5 (38%)	0.664
Hypertension	17(85%)	9(69%)	0.393
Hyperlipidemia	14 (70%)	11 (85%)	0.431
Tobacco use	5 (25%)	6 (46%)	0.270
Positive family history of CAD	9 (45%)	7 (54%)	0.888
Baseline ejection fraction	29.9 (1.7)	29.2 (1.9)	0.796
Number of arteries with stenosis >50%	2.9 (0.1)	2.6 (0.1)	0.187
Infarct Artery
RCA	17 (47%)	10 (43%)
LAD	15 (42%)	11 (48%)
LCx	4 (11%)	2 (9%)
Number of old infarcts	1.8 (0.1)	1.8 (0.2)	0.862
Anterior infarction	15 (42%)	11 (48%)
Non-anterior infarction	21 (58%)	12 (52%)
Number of vessels infused	1.7 (0.1)	N/A	N/A
LIMA	8 (24%)	N/A
Non-LIMA	25 (76%)	N/A
Number of cells injected
1,000,000	18 (90%)	N/A	N/A
500,000	2 (10%)	N/A	N/A
Medications
Aspirin	20 (100%)	12 (92%)	0.826
β Blocker	16(80%)	12 (92%)	0.641
ACE inhibitors or ARB	14 (70%)	7 (54%)	0.567
Statin	17 (85%)	11 (85%)	0.641
Clopidogrel	7 (35%)	5 (39%)	0.866

Baseline characteristics of all patients enrolled in the SCIPIO trial. Data are number (%) or mean ± SEM. N/A=not applicable, CAD=coronary artery disease, RCA=right coronary artery, LAD=left anterior descending, LCx=left circumflex, LIMA=left internal mammary artery.